The Effects of 0.01% Atropine on Adult Myopes’ Contrast Sensitivity

PurposeAtropine at a low concentration is considered a safe and effective treatment to mitigate myopia progression. However, the potential unwanted side effects of administering atropine at a low dose on visual functions other than best corrected visual acuity has not been investigated. In this stud...

Full description

Bibliographic Details
Main Authors: Ziyun Cheng, Jianhui Mei, Suqi Cao, Ran Zhang, Jiawei Zhou, Yuwen Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2021.624472/full
_version_ 1818928467486441472
author Ziyun Cheng
Jianhui Mei
Suqi Cao
Ran Zhang
Jiawei Zhou
Yuwen Wang
author_facet Ziyun Cheng
Jianhui Mei
Suqi Cao
Ran Zhang
Jiawei Zhou
Yuwen Wang
author_sort Ziyun Cheng
collection DOAJ
description PurposeAtropine at a low concentration is considered a safe and effective treatment to mitigate myopia progression. However, the potential unwanted side effects of administering atropine at a low dose on visual functions other than best corrected visual acuity has not been investigated. In this study, we investigate the short-term (12,16, and 20 h) and long-term (1, 2, and 4 weeks) effects of 0.01% atropine (i.e., 0.1 mg/ml) on contrast sensitivity (CS) in patients with myopia.MethodsThirty adults (23.33 ± 2.93 years old) with myopia between -1.00 and -6.00 diopters (D), astigmatism of -1.50 D or less, and anisometropia of 1.00 D or less, participated in this prospective, masked, placebo-controlled, randomized study. The participants were randomly assigned to receive 0.01% atropine or polyvinyl alcohol eye drops once nightly to both eyes for four weeks. CS was measured binocularly at baseline and 12, 16, 20 h, 1, 2, and 4 weeks after the first use of the eye drops.ResultsThere was no statistically significant differences of CS found between atropine and placebo-controlled groups in both short-term and long-term. There was no statistically significant interaction effect found between the time and group.ConclusionWe demonstrated no significant deleterious effect of 0.01% atropine on adult myopes’ CS.
first_indexed 2024-12-20T03:29:22Z
format Article
id doaj.art-aad3316cfcb4443f8729b4c8320a4396
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-12-20T03:29:22Z
publishDate 2021-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-aad3316cfcb4443f8729b4c8320a43962022-12-21T19:55:01ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2021-02-011510.3389/fnins.2021.624472624472The Effects of 0.01% Atropine on Adult Myopes’ Contrast SensitivityZiyun ChengJianhui MeiSuqi CaoRan ZhangJiawei ZhouYuwen WangPurposeAtropine at a low concentration is considered a safe and effective treatment to mitigate myopia progression. However, the potential unwanted side effects of administering atropine at a low dose on visual functions other than best corrected visual acuity has not been investigated. In this study, we investigate the short-term (12,16, and 20 h) and long-term (1, 2, and 4 weeks) effects of 0.01% atropine (i.e., 0.1 mg/ml) on contrast sensitivity (CS) in patients with myopia.MethodsThirty adults (23.33 ± 2.93 years old) with myopia between -1.00 and -6.00 diopters (D), astigmatism of -1.50 D or less, and anisometropia of 1.00 D or less, participated in this prospective, masked, placebo-controlled, randomized study. The participants were randomly assigned to receive 0.01% atropine or polyvinyl alcohol eye drops once nightly to both eyes for four weeks. CS was measured binocularly at baseline and 12, 16, 20 h, 1, 2, and 4 weeks after the first use of the eye drops.ResultsThere was no statistically significant differences of CS found between atropine and placebo-controlled groups in both short-term and long-term. There was no statistically significant interaction effect found between the time and group.ConclusionWe demonstrated no significant deleterious effect of 0.01% atropine on adult myopes’ CS.https://www.frontiersin.org/articles/10.3389/fnins.2021.624472/fullatropinecontrast sensitivitymyopia controlvisual perceptionmyopia
spellingShingle Ziyun Cheng
Jianhui Mei
Suqi Cao
Ran Zhang
Jiawei Zhou
Yuwen Wang
The Effects of 0.01% Atropine on Adult Myopes’ Contrast Sensitivity
Frontiers in Neuroscience
atropine
contrast sensitivity
myopia control
visual perception
myopia
title The Effects of 0.01% Atropine on Adult Myopes’ Contrast Sensitivity
title_full The Effects of 0.01% Atropine on Adult Myopes’ Contrast Sensitivity
title_fullStr The Effects of 0.01% Atropine on Adult Myopes’ Contrast Sensitivity
title_full_unstemmed The Effects of 0.01% Atropine on Adult Myopes’ Contrast Sensitivity
title_short The Effects of 0.01% Atropine on Adult Myopes’ Contrast Sensitivity
title_sort effects of 0 01 atropine on adult myopes contrast sensitivity
topic atropine
contrast sensitivity
myopia control
visual perception
myopia
url https://www.frontiersin.org/articles/10.3389/fnins.2021.624472/full
work_keys_str_mv AT ziyuncheng theeffectsof001atropineonadultmyopescontrastsensitivity
AT jianhuimei theeffectsof001atropineonadultmyopescontrastsensitivity
AT suqicao theeffectsof001atropineonadultmyopescontrastsensitivity
AT ranzhang theeffectsof001atropineonadultmyopescontrastsensitivity
AT jiaweizhou theeffectsof001atropineonadultmyopescontrastsensitivity
AT yuwenwang theeffectsof001atropineonadultmyopescontrastsensitivity
AT ziyuncheng effectsof001atropineonadultmyopescontrastsensitivity
AT jianhuimei effectsof001atropineonadultmyopescontrastsensitivity
AT suqicao effectsof001atropineonadultmyopescontrastsensitivity
AT ranzhang effectsof001atropineonadultmyopescontrastsensitivity
AT jiaweizhou effectsof001atropineonadultmyopescontrastsensitivity
AT yuwenwang effectsof001atropineonadultmyopescontrastsensitivity